Taiwan Advance Bio-Pharmaceutical Inc. (4186)
Market Closed
11 Aug, 05:30
TWSE 
NT$
9. 29
+0.25
+2.7655%
NT$
- Market Cap
- P/E Ratio
0.47% Div Yield
100,453 Volume
- Eps
NT$ 9.04
Previous Close Want to track 4186 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Taiwan Advance Bio-Pharmaceutical Inc. (4186) Statistics
Valuation metrics
Market Cap -
Enterprise value 935.66M
Trailing P/E (ttm) 29.11
Forward P/E -
PEG ratio 0.53
Price/Sales (ttm) 2.2
Price/Book (mrq) 2.82
Enterprise Value/Revenue 2.56
Enterprise Value/EBITDA 20.4
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 119.22K
Average volume (90 days) 228.6K
Price summary
52-Week low 8.41
52-Week high 17.65
Beta -
50-Day moving average 9.68
200-Day moving average 10.39
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 29 Jun 2026
Ex-Dividend Date 29 Jun 2026
Last split factor 3:1
Last split Date 28 Dec 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.08%
Operating margin 0.08%
Operational effectiveness
Return on assets 0.04%
Return on equity 0.1%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 4.05
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.31
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.56
Total debt (mrq) -
Total Debt/Equity (mrq) 0.96
Current ratio (mrq) 0.98%
Book value per share (mrq) 3.17
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
